MN/CA9 gene expression as a potential tumor marker for renal cell carcinoma

被引:0
|
作者
Pamposh Raina
S. K. Singh
Anil K. Goswami
Manoj Kumar Kashyap
Madhu Khullar
S. K. Sharma
Kailash Chander Barwal
机构
[1] Indira Gandhi Medical College,Department of Urology
[2] Postgraduate Institute of Medical Education & Research,Department of Urology
[3] Postgraduate Institute of Medical Education & Research,Department of Experimental Medicine and Biotechnology
[4] Amity University Haryana,Amity Stem Cell Institute, Amity Medical School
[5] Amity Education Valley,undefined
来源
关键词
RT-PCR; cDNA synthesis; Renal cell carcinoma; RCC; Blood; Urine;
D O I
暂无
中图分类号
学科分类号
摘要
MN/CA9 is a cell surface glycoprotein and a tumor-associated antigen. It plays a crucial role in the regulation of cell proliferation and oncogenesis. There is no ideal tumor marker currently available for renal cell carcinoma (RCC) with sufficient sensitivity and specificity. Therefore, we studied MN/CA9 gene expression in the tumor tissue, apparently normal kidney tissue, preoperative blood, and urine samples of patients with RCC. We included thirty cases of renal tumors (26 RCC and 4 benign tumors) in the study. We applied an RT-PCR assay for MN/CA9 gene expression to 26 RCC kidney tumor samples and four benign kidney tumor tissue samples. We also evaluated MN/CA9 gene expression in preoperative blood and urine samples of 15 of these cases. Additionally, thirty-five grossly normal renal tissue samples, including 21 from kidneys with RCC, were also evaluated for gene expression. The RT-PCR analysis revealed that twenty-one out of 26 RCC tissue samples showed MN/CA9 gene expression compared to three out of 35 non-malignant renal tissue samples (p < 0.05). Two out of four benign renal tissue samples also expressed this gene. We also observed MN/CA9 gene expression in nine out of 15 blood samples and four out of 15 urine samples. All patients with urinary MN/CA9 gene expression showed expression in blood and tumor tissue samples. We found a correlation in terms of MN/CA9 expression between blood and tumor tissue samples of RCC patients as those who exhibit MN/CA9 expression in blood were also positive at the tumor tissue levels. The difference in MN/CA9 gene expression in tumor tissue, blood, and urine samples in relation to the stage of the disease, nuclear grade, and histological cell-type was not statistically significant. However, all the three patients who had metastatic RCC had MN/CA9 gene expression in their blood. The existence of a tumor-associated antigen such as MN/CA9 may present a possible target for molecular diagnosis and management of RCC.
引用
收藏
页码:333 / 343
页数:10
相关论文
共 50 条
  • [41] PADI4 stimulates esophageal squamous cell carcinoma tumor growth and up-regulates CA9 expression
    Liu, Chunyan
    Tang, Junyi
    Li, Chang
    Pu, Guangbo
    Yang, Dongxia
    Chang, Xiaotian
    MOLECULAR CARCINOGENESIS, 2019, 58 (01) : 66 - 75
  • [42] Carbonic anhydrase 9 (CA9) expression in tumor cells enhances sensitivity to tirapazamine
    Hye-Jin Shin
    Joo-Young Kim
    Chong-Woo Yoo
    Stephen A. Roberts
    Sun Lee
    Soo-Jin Choi
    Hee-Young Lee
    Doo-Hyun Lee
    Tae Hyun Kim
    Kwan Ho Cho
    Journal of Cancer Research and Clinical Oncology, 2008, 134 : 397 - 404
  • [43] Comparative expression analysis of the hypoxia marker gene Carbonic anhydrase 9 (CA9) in different grades of human malignant glioblastoma
    Said, H. M.
    Hagemann, C.
    Schoemig, B.
    Vince, G. H.
    Flentje, M.
    Vordermark, D.
    FEBS JOURNAL, 2009, 276 : 220 - 221
  • [44] Carbonic anhydrase 9 (CA9) expression in tumor cells enhances sensitivity to tirapazamine
    Shin, Hye-Jin
    Kim, Joo-Young
    Yoo, Chong-Woo
    Roberts, Stephen A.
    Lee, Sun
    Choi, Soo-Jin
    Lee, Hee-Young
    Lee, Doo-Hyun
    Kim, Tae Hyun
    Cho, Kwan Ho
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (03) : 397 - 404
  • [45] Clinical utility of serum CA9 in conventional renal cell cancer
    Li, G.
    Feng, G.
    Gentil-Perret, A.
    Genin, C.
    Tostain, J.
    BULLETIN DU CANCER, 2008, 95 : S13 - S13
  • [46] A potential for tissue restrictive gene therapy in renal cell carcinoma using MN/CA IX promoter
    Ou, YC
    Gardner, TA
    Kao, C
    Zhau, HE
    Chung, LW
    ANTICANCER RESEARCH, 2005, 25 (2A) : 881 - 886
  • [47] Immunohistochemical (IHC) Expression of Carbonic Anhydrase IX (CA9) in Papillary (PRCC) and Chromophobe (CHRCC) Renal Cell Carcinoma Is Associated with Necrosis
    Goyal, R.
    Zhu, B.
    Parimi, V.
    Bishu, S.
    Lin, X.
    Yang, X. J.
    Rohan, S. M.
    MODERN PATHOLOGY, 2011, 24 : 194A - 195A
  • [48] Immunohistochemical (IHC) Expression of Carbonic Anhydrase IX (CA9) in Papillary (PRCC) and Chromophobe (CHRCC) Renal Cell Carcinoma Is Associated with Necrosis
    Goyal, R.
    Zhu, B.
    Parimi, V.
    Bishu, S.
    Lin, X.
    Yang, X. J.
    Rohan, S. M.
    LABORATORY INVESTIGATION, 2011, 91 : 194A - 195A
  • [49] Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines
    Jakubicková, L
    Biesová, Z
    Pastoreková, S
    Kettmann, R
    Pastorek, J
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 26 (04) : 1121 - 1127
  • [50] Higher Expression of CDKN2A Gene Is Potential Prognostic Marker for Clear Cell Renal Cell Carcinoma
    Tawedrous, Eriny
    Wala, Samantha J.
    Saleeb, Rola
    Rotondo, Fabio
    Ding, Qiang
    Yousef, George M.
    MODERN PATHOLOGY, 2016, 29 : 266A - 266A